Otsuka Holdings Co., Ltd. (TYO:4578)

Market Cap	4.35T
Revenue (ttm)	2.33T
Net Income (ttm)	343.12B
Shares Out	537.09M
EPS (ttm)	633.76
PE Ratio	12.79
Forward PE	15.02
Dividend	120.00 (1.47%)
Ex-Dividend Date	Dec 27, 2024

Volume	878,400
Average Volume	1,205,860
Open	8,190.00
Previous Close	8,108.00
Day's Range	8,027.00 - 8,192.00
52-Week Range	6,066.00 - 9,669.00
Beta	0.07
RSI	64.81
Earnings Date	Apr 30, 2025

About Otsuka Holdings

Otsuka Holdings Co., Ltd. engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. The company develops pharmaceutical products in the fields of psychiatry, neurology, oncology, cardiovascular and renal system, digestive system, ophthalmology, and diagnostics, as well as intravenous solutions and medical devices. It also provides clinical testing, medical equipment, food products, cosmetics, functional food products, chemical products, soft drinks, beverages, analytical and measurement instruments, nutr...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1921
• Employees: 35,338
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4578

Financial Performance

In 2024, Otsuka Holdings's revenue was 2.33 trillion, an increase of 15.42% compared to the previous year's 2.02 trillion. Earnings were 343.12 billion, an increase of 182.13%.